epi-743
Showing 1 - 9 of 9
Autism Spectrum Disorder Trial (EPI-743)
Withdrawn
- Autism Spectrum Disorder
- EPI-743
- (no location specified)
Jan 20, 2022
Mitochondrial Disease, Neurology, Myopathy Trial run by the NHGRI (EPI-743, Placebo)
Completed
- Mitochondrial Disease
- +2 more
- EPI-743
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 19, 2021
Noise-induced Hearing Loss Trial in Gainesville (EPI-743, Placebo)
Completed
- Noise-induced Hearing Loss
- EPI-743
- Placebo
-
Gainesville, FloridaUniversity of Florida
Nov 16, 2020
Pearson Syndrome Trial in United States (EPI-743)
Terminated
- Pearson Syndrome
- EPI-743
-
Orange, California
- +3 more
Nov 16, 2020
Rett Syndrome Trial in Siena (EPI-743, Placebo)
Completed
- Rett Syndrome
- EPI-743
- Placebo
-
Siena, ItalyUniversity of Siena
Jul 23, 2018
Methylmalonic Aciduria and Homocystinuria,Cblc Type, Genetic Disease, Retinopathy Trial in Rome (Epi-743, Placebo
Completed
- Methylmalonic Aciduria and Homocystinuria,Cblc Type
- +2 more
- Epi-743
- Placebo supplementation
-
Rome, ItalyBambino Gesù Hospital and Research Institute
Apr 22, 2017
Friedreich's Ataxia Trial in Tampa (EPI-743)
Completed
- Friedreich's Ataxia
- EPI-743
-
Tampa, FloridaUniversity of South Florida
Jun 28, 2016
Leber's Hereditary Optic Neuropathy Trial in Los Angeles (EPI-743)
No longer available
- Leber's Hereditary Optic Neuropathy
- EPI-743
-
Los Angeles, CaliforniaDoheny Eye Institute / UCLA
Nov 24, 2014
Tourette Syndrome Trial in New Haven (EPI-743)
Completed
- Tourette Syndrome
- EPI-743
-
New Haven, ConnecticutYale Child Study Center
Mar 4, 2014